SCM
EXAS

Shaolin Capital Management’s Exact Sciences EXAS Stock Holding History

Shaolin Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-29,100
Closed -$2.69M – 173
2019
Q4 		$2.69M Buy
+29,100
New +$2.56M 0.43% 76

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Shaolin Capital Management's EXAS Position: Q1 2020 in Review

Shaolin Capital Management sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 29,100 shares — an estimated $2.69M sold.

Shaolin Capital Management first reported a position in EXAS in Q4 2019 and held it in 1 quarter. The position peaked at $2.69M in Q4 2019. 476 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

  • Shaolin Capital Management reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
  • Shaolin Capital Management sold 29,100 Exact Sciences shares in Q1 2020, an estimated $2.69M.
  • Shaolin Capital Management first reported a position in Exact Sciences in Q4 2019 and held it in 1 quarter.
  • Shaolin Capital Management's Exact Sciences position peaked at $2.69M in Q4 2019.
  • 476 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on Shaolin Capital Management's 13F filing for Q1 2020, filed 15 May 2020.